Fig. 2From: Methylation of SERPINA1 gene promoter may predict chronic obstructive pulmonary disease in patients affected by acute coronary syndromeBisulfite–polymerase chain reaction (PCR) sequencing of the SERPINA1 promoter of DNAs from blood samples belonging to acute coronary syndrome (ACS) patients a with chronic obstructive pulmonary disease (COPD+) and b without COPD (COPD−). In both panels: stratification of bisulfite–PCR sequences according to ACS subgroup and SERPINA1 hyper- and hypomethylation status. Filled-in and clear circles represent methylated and unmethylated CpGs, respectively. The CpGs within the SERPINA1 promoter are numbered across the top of the grid. Each row represents one PCR product/analyzed sequence. Samples showing more than or equal to 5 out of 8 (≥ 50%) methylated CpGs were considered hypermethylated; c frequencies of SERPINA1 promoter hypermethylation in COPD+ and COPD− samples. *p < 0.05Back to article page